O
HRMY icon

Ossiam’s Harmony Biosciences HRMY Stock Holding History

Ossiam’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Buy
+55,500
New +$1.75M 0.03% 291
2025
Q4 		– Sell
-55,500
Closed -$1.53M – 507
2025
Q3 		$1.53M Buy
+55,500
New +$1.91M 0.02% 387

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ossiam's HRMY Position: Q2 2026 in Review

Ossiam opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 55,500 shares worth $2.02M. The stake represents 0.03% of the portfolio and ranks #291 among its holdings. This is a return to the name: Ossiam previously reported a position in HRMY as recently as Q3 2025.

Ossiam first reported a position in HRMY in Q3 2025 and has held it in 2 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Ossiam held 55,500 shares of Harmony Biosciences worth $2.02M as of Q2 2026.
  • Harmony Biosciences was a new Ossiam position in Q2 2026.
  • Harmony Biosciences made up 0.03% of Ossiam's portfolio in Q2 2026, its #291 holding.
  • Ossiam first reported a position in Harmony Biosciences in Q3 2025 and has held it in 2 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.